{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:17:41Z","timestamp":1762352261442},"reference-count":122,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.lpm.2013.01.059","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T16:00:52Z","timestamp":1366387252000},"page":"e235-e244","source":"Crossref","is-referenced-by-count":16,"special_numbering":"P2","title":["Paraneoplastic disorders of the peripheral nervous system"],"prefix":"10.1016","volume":"42","author":[{"given":"Jean-Christophe","family":"Antoine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Camdessanch\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2013.01.059_bib0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/brain\/88.3.427","article-title":"The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma","volume":"88","author":"Croft","year":"1965","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.059_bib0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/brain\/93.3.629","article-title":"The incidence of the non-metastatic neurological syndromes of obscure origin in the reticuloses","volume":"93","author":"Currie","year":"1970","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.059_bib0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/1531-8249(199902)45:2<162::AID-ANA5>3.0.CO;2-R","article-title":"Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies","volume":"45","author":"Benyahia","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ni0303-201","article-title":"Observing the invisible: successful tumor immunity in humans","volume":"4","author":"Darnell","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","article-title":"Encephalitis and antibodies to synaptic and neuronal cell surface proteins","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0030","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neurol.2011.08.001","article-title":"New concepts in paraneoplastic neurological syndromes","volume":"167","author":"Honnorat","year":"2011","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.lpm.2013.01.059_bib0035","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp-2011-301237","article-title":"Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition","volume":"83","author":"Zuliani","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.059_bib0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0092-8674(91)90184-Z","article-title":"HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and sex-lethal","volume":"67","author":"Szabo","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.lpm.2013.01.059_bib0045","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/NEN.0b013e31824d1df2","article-title":"The collapsin response mediator protein 5 onconeural protein is expressed in Schwann cells under axonal signals and regulates axon-Schwann cell interactions","volume":"71","author":"Camdessanche","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0050","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0166-2236(89)90109-4","article-title":"Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder","volume":"12","author":"Vincent","year":"1989","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.lpm.2013.01.059_bib0055","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1097\/JTO.0b013e3181f23f04","article-title":"Caspr2 antibodies in patients with thymomas","volume":"5","author":"Vincent","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0060","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0065","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.059_bib0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mus.20100","article-title":"Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies)","volume":"30","author":"Kuntzer","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.059_bib0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis\/sensory neuronopathy. A clinical study of 71 patients","volume":"71","author":"Dalmau","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2013.01.059_bib0080","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients","volume":"124","author":"Graus","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.059_bib0085","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1212\/WNL.44.12.2258","article-title":"Indolent anti-Hu-associated paraneoplastic sensory neuropathy","volume":"44","author":"Graus","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0090","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/brain\/awf006","article-title":"Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients","volume":"125","author":"Camdessanche","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.059_bib0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ana.410020103","article-title":"Subacute sensory neuropathy: a remote effect of carcinoma","volume":"2","author":"Horwich","year":"1977","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0100","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ana.410440620","article-title":"Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy","volume":"44","author":"Molinuevo","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.410400118","article-title":"Motor neuron disease: a paraneoplastic process associated with anti-hu antibody and small-cell lung carcinoma","volume":"40","author":"Verma","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1212\/WNL.44.1.181-a","article-title":"Anti-Hu-associated peripheral nerve and muscle microvasculitis","volume":"44","author":"Younger","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0115","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/(SICI)1097-4598(199807)21:7<850::AID-MUS2>3.0.CO;2-5","article-title":"Paraneoplastic demyelinating neuropathy, subacute sensory neuropathy, and anti-Hu antibodies: clinicopathological study of an autopsy case","volume":"21","author":"Antoine","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.059_bib0120","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/1531-8249(20010201)49:2<214::AID-ANA41>3.0.CO;2-W","article-title":"Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy","volume":"49","author":"Antoine","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jnnp.2007.138016","article-title":"Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2\/CRMP5 antibodies","volume":"80","author":"Honnorat","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.059_bib0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/jnnp.2005.068775","article-title":"Anti-Ma2 associated paraneoplastic neurological syndrome presenting as encephalitis and progressive muscular atrophy","volume":"77","author":"Waragai","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.lpm.2013.01.059_bib0135","first-page":"A188","article-title":"Purkinje cell antibody type 1 (PCA-1, Anti-Yo): peripheral nerve manifestations","volume":"66","author":"Tracy","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mus.22168","article-title":"Pure monomelic sensory neuronopathy associated with anti-yo antibodies","volume":"45","author":"Taieb","year":"2012","journal-title":"Muscle Nerve"},{"issue":"Pt\u00a03","key":"10.1016\/j.lpm.2013.01.059_bib0145","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","article-title":"The Lambert-Eaton myasthenic syndrome. A review of 50 cases","volume":"111","author":"O\u2019Neill","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.059_bib0150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0303-8467(02)00054-9","article-title":"Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases","volume":"104","author":"Wirtz","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.lpm.2013.01.059_bib0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","article-title":"Screening for tumours in paraneoplastic syndromes: report of an EFNS task force","volume":"18","author":"Titulaer","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/01.WNL.0000130254.27019.14","article-title":"The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands","volume":"63","author":"Wirtz","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0165","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1212\/WNL.54.11.2176","article-title":"Lambert-Eaton myasthenic syndrome: electrodiagnostic findings and response to treatment","volume":"54","author":"Tim","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0170","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/01.WNL.0000037485.56217.5F","article-title":"Seronegative Lambert-Eaton myasthenic syndrome: study of 110 Japanese patients","volume":"59","author":"Nakao","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0175","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/jnnp.73.6.766","article-title":"Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome","volume":"73","author":"Wirtz","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.059_bib0180","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/WNL.59.7.1085","article-title":"Postexercise facilitation of reflexes is not common in Lambert-Eaton myasthenic syndrome","volume":"59","author":"Odabasi","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/mus.20389","article-title":"Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome","volume":"32","author":"Oh","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.059_bib0190","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/WNL.42.10.1944","article-title":"Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome","volume":"42","author":"Clouston","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0195","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1200\/JCO.2008.17.5133","article-title":"Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome","volume":"26","author":"Titulaer","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0200","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","article-title":"Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes","volume":"332","author":"Lennon","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.01.059_bib0205","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/WNL.48.5.1261","article-title":"Antibodies to synthetic peptides of the alpha1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome","volume":"48","author":"Takamori","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-510X(96)05303-8","article-title":"Incidence of serum anti-P\/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome","volume":"147","author":"Motomura","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lpm.2013.01.059_bib0215","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/jnnp.2006.091504","article-title":"Transient neonatal Lambert-Eaton syndrome","volume":"77","author":"Lecky","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.059_bib0220","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s00415-008-0988-2","article-title":"Transient neonatal Lambert-Eaton syndrome","volume":"255","author":"Reuner","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0225","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0022-510X(99)00125-2","article-title":"Calcium channel peptide can cause an autoimmune-mediated model of Lambert-Eaton myasthenic syndrome in rats","volume":"166","author":"Komai","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lpm.2013.01.059_bib0230","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/WCO.0b013e328347b307","article-title":"Movement disorders in paraneoplastic and autoimmune disease","volume":"24","author":"Panzer","year":"2011","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0235","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awf178","article-title":"Phenotypic variants of autoimmune peripheral nerve hyperexcitability","volume":"125","author":"Hart","year":"2002","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.lpm.2013.01.059_bib0240","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/mus.20536","article-title":"Clinical electrophysiological characterization of the acquired neuromyotonia phenotype of autoimmune peripheral nerve hyperexcitability","volume":"33","author":"Maddison","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.059_bib0245","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0250","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1097-4598(199703)20:3<299::AID-MUS6>3.0.CO;2-6","article-title":"Antibodies to potassium channels of PC12 in serum of Isaacs\u2019 syndrome: Western blot and immunohistochemical studies","volume":"20","author":"Arimura","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.059_bib0255","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.059_bib0260","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0265","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0270","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1600-065X.2003.00056.x","article-title":"Monoclonal gammopathies of undetermined significance: a review","volume":"194","author":"Kyle","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1016\/j.lpm.2013.01.059_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ana.410060102","article-title":"The natural history of peripheral neuropathy in primary systemic amyloidosis","volume":"6","author":"Kelly","year":"1979","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0280","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/WCO.0b013e328357bdf6","article-title":"Amyloid neuropathies","volume":"25","author":"Adams","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0285","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00005792-197507000-00001","article-title":"Amyloidosis: review of 236 cases","volume":"54","author":"Kyle","year":"1975","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2013.01.059_bib0290","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3816\/CLM.2005.n.048","article-title":"Amyloidosis: diagnosis and management","volume":"6","author":"Gertz","year":"2005","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.lpm.2013.01.059_bib0295","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mus.22229","article-title":"Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy","volume":"45","author":"Mathis","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.059_bib0300","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1529-8027.2006.00107.x","article-title":"Isolated amyloidosis presenting with lumbosacral radiculoplexopathy: description of two cases and pathogenic review","volume":"11","author":"Ladha","year":"2006","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.lpm.2013.01.059_bib0305","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1529-8027.2012.00406.x","article-title":"Amyloid-like IgM deposition neuropathy: a distinct clinico-pathologic and proteomic profiled disorder","volume":"17","author":"Figueroa","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.lpm.2013.01.059_bib0310","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2013.01.059_bib0315","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1529-8027.2002.02007.x","article-title":"Cryoglobulinemia is a frequent cause of peripheral neuropathy in undiagnosed referral patients","volume":"7","author":"Gemignani","year":"2002","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.lpm.2013.01.059_bib0320","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/jnnp.2005.071175","article-title":"Peripheral neuropathies in Waldenstr\u00f6m's macroglobulinaemia","volume":"77","author":"Levine","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.059_bib0325","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ajh.2830450105","article-title":"Peripheral neuropathy in IgM monoclonal gammopathy and Waldenstr\u00f6m's macroglobulinemia: a frequent complication in elderly males with low MAG-reactive serum monoclonal component","volume":"45","author":"Baldini","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0330","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1388-2457(01)00469-2","article-title":"Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies","volume":"112","author":"Attarian","year":"2001","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0335","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mus.20678","article-title":"Terminal latency index in neuropathy with antibodies against myelin-associated glycoproteins","volume":"35","author":"Lupu","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.059_bib0340","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","article-title":"The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies","volume":"124","author":"Willison","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.059_bib0345","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/mus.20361","article-title":"Neuropathology of paraneoplastic neuropathy with anti-disialosyl antibody","volume":"32","author":"Kobayashi","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.059_bib0350","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2141.2003.04651.x","article-title":"Multifocal motor neuropathy caused by a B-cell lymphoma producing a monoclonal IgM autoantibody against peripheral nerve myelin glycolipids GM1 and GD1b","volume":"123","author":"Noguchi","year":"2003","journal-title":"Br J Haematol"},{"issue":"Pt\u00a05","key":"10.1016\/j.lpm.2013.01.059_bib0355","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/brain\/118.5.1233","article-title":"Non-Hodgkin malignant lymphomas and peripheral neuropathies\u201313 cases","volume":"118","author":"Vallat","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.059_bib0360","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.34.6.712","article-title":"The Crow-Fukase syndrome: a study of 102 cases in Japan","volume":"34","author":"Nakanishi","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0365","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2013.01.059_bib0370","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.V87.4.1458.bloodjournal8741458","article-title":"Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome","volume":"87","author":"Gherardi","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2013.01.059_bib0375","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4","article-title":"Overproduction of vascular endothelial growth factor\/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome","volume":"21","author":"Watanabe","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.059_bib0380","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/brain\/awh519","article-title":"Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis","volume":"128","author":"Scarlato","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.059_bib0385","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1468-1331.2010.03312.x","article-title":"Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases","volume":"18","author":"Larue","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0390","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1529-8027.2012.00376.x","article-title":"Heterogeneous spectrum of neuropathies in Waldenstr\u00f6m's macroglobulinemia: a diagnostic strategy to optimize their management","volume":"17","author":"Viala","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.lpm.2013.01.059_bib0395","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/1097-0142(19821015)50:8<1491::AID-CNCR2820500808>3.0.CO;2-Q","article-title":"Peripheral nerve damage during multiple myeloma and Waldenstr\u00f6m's macroglobulinemia: an ultrastructural and immunopathologic study","volume":"50","author":"Vital","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.lpm.2013.01.059_bib0400","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1212\/WNL.31.1.24","article-title":"The spectrum of peripheral neuropathy in myeloma","volume":"31","author":"Kelly","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0405","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/01.wco.0000173462.17135.ee","article-title":"Paraneoplastic syndromes of the peripheral nerves","volume":"18","author":"Rudnicki","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0410","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/jnnp.67.1.7","article-title":"Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies","volume":"67","author":"Antoine","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.059_bib0415","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.0b013e31820d62eb","article-title":"Spectrum of paraneoplastic disease associated with lymphoma","volume":"76","author":"Briani","year":"2011","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.lpm.2013.01.059_bib0420","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.2007.125930","article-title":"Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis?","volume":"79","author":"Viala","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.059_bib0425","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1212\/WNL.48.6.1671","article-title":"Lymphoproliferative disorders and motor neuron disease: an update","volume":"48","author":"Gordon","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0430","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1212\/WNL.40.6.960","article-title":"Paraneoplastic motor neuron disease and renal cell carcinoma: improvement after nephrectomy","volume":"40","author":"Evans","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0435","series-title":"Vasculitis and the nervous system","first-page":"849","article-title":"Paraneoplastic vasculitis of the peripheral nervous system","author":"Oh","year":"1997"},{"key":"10.1016\/j.lpm.2013.01.059_bib0440","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/jnnp.60.2.188","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with carcinoma","volume":"60","author":"Antoine","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.059_bib0445","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00415-004-0317-3","article-title":"Risk of cancer in patients with Guillain-Barre syndrome (GBS). A population-based study","volume":"251","author":"Vigliani","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0450","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies","volume":"343","author":"Vernino","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.01.059_bib0455","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archneurol.2009.78","article-title":"Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments","volume":"66","author":"McKeon","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0460","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1073\/pnas.121170798","article-title":"Autoimmunity to beta IV spectrin in paraneoplastic lower motor neuron syndrome","volume":"98","author":"Berghs","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2013.01.059_bib0465","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/jnnp.2003.032193","article-title":"Antiganglioside antibodies in paraneoplastic peripheral neuropathies","volume":"75","author":"Antoine","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.059_bib0470","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1212\/WNL.51.6.1738","article-title":"Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma","volume":"51","author":"Weiss","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0475","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/jnnp.74.4.507","article-title":"Paraneoplastic ophthalmoplegia and subacute motor axonal neuropathy associated with anti-GQ1b antibodies in a patient with malignant melanoma","volume":"74","author":"Kloos","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.059_bib0480","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0035-3787(09)70017-7","article-title":"Proposition of diagnostic criterion of sensitive neuronopathy","volume":"165","author":"Camdessanche","year":"2009","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.lpm.2013.01.059_bib0485","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1529-8027.2012.00411.x","article-title":"A clinical pattern-based etiological diagnostic strategy for sensory neuronopathies: a French collaborative study","volume":"17","author":"Camdessanche","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.lpm.2013.01.059_bib0490","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007853","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"249","author":"Quasthoff","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0495","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/1097-0142(19841001)54:7<1269::AID-CNCR2820540707>3.0.CO;2-9","article-title":"Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies","volume":"54","author":"Thompson","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.lpm.2013.01.059_bib0500","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1200\/JCO.2010.32.0440","article-title":"Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS","volume":"29","author":"Titulaer","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0505","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/01.wnl.0000281663.81079.24","article-title":"SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome","volume":"70","author":"Sabater","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0510","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1200\/JCO.2008.20.6169","article-title":"SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival","volume":"27","author":"Titulaer","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0515","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/jnnp.49.9.1007","article-title":"Nerve and muscle microvasculitis in peripheral neuropathy: a remote effect of cancer?","volume":"49","author":"Vincent","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.059_bib0520","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/1097-4598(200012)23:12<1800::AID-MUS3>3.0.CO;2-X","article-title":"Paraneoplastic syndromes of the spinal cord, nerve, and muscle","volume":"23","author":"Rudnicki","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.059_bib0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00130404-200601000-00001","article-title":"Primary lymphoma of the nervous system","volume":"12","author":"Baehring","year":"2006","journal-title":"Cancer J"},{"key":"10.1016\/j.lpm.2013.01.059_bib0530","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1093\/brain\/awh247","article-title":"FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes","volume":"127","author":"Younes-Mhenni","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.059_bib0535","first-page":"513","article-title":"18F-FDG PET\/CT in myeloma with presumed solitary plasmocytoma of bone","volume":"22","author":"Nanni","year":"2008","journal-title":"In Vivo"},{"key":"10.1016\/j.lpm.2013.01.059_bib0540","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(06)70679-2","article-title":"Peripheral nervous system involvement in patients with cancer","volume":"6","author":"Antoine","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0545","first-page":"CD003279","article-title":"Treatment for Lambert-Eaton myasthenic syndrome","volume":"2","author":"Keogh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2013.01.059_bib0550","first-page":"341","article-title":"Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine","volume":"7","author":"Lindquist","year":"2011","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.lpm.2013.01.059_bib0555","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2010.03019.x","article-title":"Guidelines for treatment of autoimmune neuromuscular transmission disorders","volume":"17","author":"Skeie","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0560","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/WNL.42.3.536","article-title":"Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies","volume":"42","author":"Graus","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0565","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","article-title":"Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone","volume":"68","author":"Keime-Guibert","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.059_bib0570","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.60.4.388","article-title":"Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies","volume":"60","author":"Uchuya","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.059_bib0575","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00415-005-0882-0","article-title":"An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes","volume":"253","author":"Shams\u2019ili","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0580","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S1474-4422(11)70245-9","article-title":"Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies","volume":"10","author":"Titulaer","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2013.01.059_bib0585","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1212\/WNL.34.4.480","article-title":"Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome","volume":"34","author":"Newsom-Davis","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.059_bib0590","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jnnp.2009.197632","article-title":"The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome","volume":"82","author":"Maddison","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 2","key":"10.1016\/j.lpm.2013.01.059_bib0595","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/brain\/116.2.453","article-title":"Immunological associations of acquired neuromyotonia (Isaacs\u2019 syndrome). Report of five cases and literature review","volume":"116","author":"Newsom-Davis","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.059_bib0600","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0002-9343(02)01208-1","article-title":"Stem cell transplantation for the management of primary systemic amyloidosis","volume":"113","author":"Gertz","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2013.01.059_bib0605","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa070484","article-title":"High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis","volume":"357","author":"Jaccard","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.01.059_bib0610","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ajh.22050","article-title":"POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management","volume":"86","author":"Dispenzieri","year":"2011","journal-title":"Am J Hematol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498213005137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498213005137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T17:23:01Z","timestamp":1595697781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498213005137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":122,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0755498213005137"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2013.01.059","relation":{},"ISSN":["0755-4982"],"issn-type":[{"type":"print","value":"0755-4982"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}